Schizophrenia and sudden cardiac death—A review

References

• Mortensen PB. Mortality and physical illness in schizophrenia. The epidemiology of schizophrenia, RM Murray, PB Jones, E Susse, J Van Os, M Cannon. Cambridge University Press, Cambridge 2003
   Google Scholar
• Brown S, Inskip H, Barraclough B. Causes of excess mortality of schizophrenia. Br J Psychiatry 2000; 177: 212–17
   PubMed Web of Science ®Google Scholar
• Bandelow B, Fritze J, Ruther E. Increased mortality in schizophrenia and the possible influence of antipsychotic treatment. Int J Psych Clin Pract 1998; 2(Suppl 2)S49–S57
   Google Scholar
• Straus SMJM, Bleumink GS, Dieleman JP, van der Lei J, Stricker BHC, Sturkenboom MCJM. The incidence of sudden cardiac death in general population. J Clin Epidemiol 2004; 57: 98–102
   PubMed Web of Science ®Google Scholar
• Jindal R, MacKenzie EM, Baker GB, Yeragani VK. Cardiac risk and schizophrenia. J Psychiatry Neurosci 2005; 30: 393–5
   PubMed Web of Science ®Google Scholar
• Zipes DP, Wellens HJJ. Sudden cardiac death. Circulation 1998; 98: 2334–51
   PubMed Web of Science ®Google Scholar
• Heilä H, Haukka J, Suvisaari J, Lönnqvist J. Mortality among patients with schizophrenia and reduced psychiatric hospital care. Psychol Med 2005; 35: 725–32
   PubMed Web of Science ®Google Scholar
• Chute D, Grove C, Rajasekhara B, Smialek JE. Schizophrenia and sudden death: A medical examiner case study. Am J Forensic Med Pathol 1999; 20: 131–5
   PubMed Web of Science ®Google Scholar
• Ösby U, Correia N, Brandt L, Ekbom A, Sparen P. Mortality and causes of death in schizophrenia in Stockholm County, Sweden. Sch Research 2000; 45: 21–8
   PubMed Web of Science ®Google Scholar
• Stark C, MacLeod M, Hall D, O'Brien F, Pelosi A. Mortality after discharge from long-term psychiatric care in Scotland, 1977–94: A retrospective cohort study. BMC Public Health 2003; 3: 30–4
   PubMed Web of Science ®Google Scholar
• Appleby L, Thomas S, Ferrier N, Lewis G, Shaw J, Amos T. Sudden unexplained death in psychiatric in-patients. Br J Psychiatry 2000; 176: 405–6
   PubMed Web of Science ®Google Scholar
• Ruschena D, Mullen PE, Burgess P, Cordner SM, Barry-Walsh J, Drummer OH, et al. Sudden death in psychiatric patients. Br J Psychiatry 1998; 172: 331–6
   PubMed Web of Science ®Google Scholar
• Mehtonen OP, Aranko K, Mälkonen L, Vapaatalo H. A survey of sudden death associated with the use of antipsychotic or antidepressant drugs: 49 cases in Finland. Acta Psych Scand 1991; 84: 58–64
   PubMed Web of Science ®Google Scholar
• Ray WA, Meredith S, Thapa PB, Meador KG, Hall K, Murray KT. Antipsychotics and the risk of sudden cardiac death. Arch Gen Psychiatry 2001; 58: 1161–7
   PubMed Web of Science ®Google Scholar
• Hennessy S, Bilker WB, Knauss JS, Margolis DJ, Kimmel SE, Reynolds RF, et al. Cardiac arrest and ventricular arrhythmia in patients taking antipsychotic drugs: Cohort study using administrative data. BMJ 2002; 325: 1070–2
   PubMed Web of Science ®Google Scholar
• Reilly JG, Ayis SA, Ferrier IN, Jones SJ, Thomas SHL. Thioridazine and sudden unexplained death in psychiatric in-patients. Br J Psychiatry 2002; 180: 515–22
   PubMed Web of Science ®Google Scholar
• Waddington JL, Youssef HA, Kinsella A. Mortality in schizophrenia. Antipsychotic polypharmacy and the absence of adjunctive anticholinergics over the course of a 10-year prospective study. Br J Psychiatry 1998; 173: 325–9
   PubMed Web of Science ®Google Scholar
• Joukamaa M, Heliövaara M, Knekt P, Aromaa A, Raitasalo R, Lehtinen V. Schizophrenia, neuroleptic medication and mortality. Br J Psychiatry 2006; 188: 122–7
   PubMed Web of Science ®Google Scholar
• La Rovere MT, Bersano C, Gnemmi M, Specchia, Schwartz PJ. Exercise-induced increase in baroreflex sensitivity predicts improved prognosis after myocardial infarction. Circulation 2002;106:945–9.
   PubMed Web of Science ®Google Scholar
• Huikuri HV, Mäkikallio TH, Peng C-K, Goldberg AL, Hintze U, Moller M. Fractal correlation properties of R-R interval dynamics and mortality in patients with depressed left ventricular function after an acute myocardial infarction. Circulation 2000; 101: 47–53
   PubMed Web of Science ®Google Scholar
• Huikuri HV, Mäkikallio TH, Raatikainen MJP, Perkiömäki J, Castellanos A, Myerburg RJ. Prediction of sudden cardiac death: Appraisal of the studies and methods assessing sudden arrhythmic death. Circulation 2003; 108: 110–15
   PubMed Web of Science ®Google Scholar
• Bär KJ, Letzsch A, Jochum T, Wagner G, Greiner W, Sauer H. Loss of efferent vagal activity in acute schizophrenia. J Psychiatry Res 2005; 39: 519–27
   PubMed Web of Science ®Google Scholar
• Williams LM, Das P, Harris AW, Liddell BB, Brammer MJ, Olivieri G, et al. Dysregulation of arousal and amygdala-prefrontal systems in paranoid schizophrenia. Am J Psychiatry 2004; 161: 480–9
   PubMed Web of Science ®Google Scholar
• Ridler K, Veijola JM, Tanskanen P, Miettunen J, Chitnis X, Sucling J, et al. Fronto-cerebellar systems are associated with infant motor and adult executive functions in healthy adults but not in schizophrenia. Proc Natl Acad Sci USA 2006; 103: 15651–6
   PubMed Web of Science ®Google Scholar
• Davatzikos C, Shen D, Gur RC, Wu X, Liu D, Fan Y, et al. Whole-brain morphometric study of schizophrenia revealing a spatially complex set of focal abnormalities. Arch Gen Psychiatry 2005; 62: 1218–27
   PubMed Web of Science ®Google Scholar
• Crithley HD, Taggart P, Sutton PM, Holdright DR, Batchvarov V, Hnatkova K, et al. Mental stress and sudden cardiac death: Asymmetric midbrain activity as a linking mechanism. Brain 2005; 128: 75–85
   PubMed Web of Science ®Google Scholar
• Cohen H, Loewenthal U, Mater M, Kotler M. Association of autonomic dysfunction and clozapine. Heart rate variability and risk for sudden death in patients with schizophrenia on long-term psychotropic medication. Br J Psychiatry 2001; 179: 167–71
   PubMed Web of Science ®Google Scholar
• Silke B, Cambell C, King DJ. The potential cardiotoxicity of antipsychotic drugs as assessed by heart rate variability. J Psychopharmacol 2002; 16: 355–60
   PubMed Web of Science ®Google Scholar
• Kang UG, Kwon JS, Ahn YM, et al. Electrocardiographic abnormalities in patients treated with clozapine. J Clin Psychiatry 2000; 61: 441–46
   PubMed Web of Science ®Google Scholar
• Glassman AH, Bigger JT. Antipsychotic drugs: Prolonged QTc interval, torsades de pointes, and sudden death. Am J Psychiatry 2001; 158: 1774–82
   PubMed Web of Science ®Google Scholar
• Titier K, Girodet P-O, Verdoux H, et al. Atypical antipsychotics. From potassium channels to Torsade de Pointes and sudden death. Drug Safety 2005; 28: 35–51
   PubMed Web of Science ®Google Scholar
• Hassaballa HA, Balk RA. Torsades de pointes associated with the administration of intravenous haloperidol. Am J Therapeutics 2003; 10: 58–60
   PubMedGoogle Scholar
• Welch R, Chue P. Antipsychotic agents and QT changes. J Psychiatry Neurosci 2000; 25: 154–60
   PubMed Web of Science ®Google Scholar
• Kelly DL, Love RC. Ziprasidone and the OTc interval: Pharmacokinetic and pharmacodynamic considerations. Psychopharmacol Bull 2001; 35: 66–79
   PubMedGoogle Scholar
• Kiviniemi AM, Tulppo MP, Wichterle D, Hautala AJ, Tiinanen S, Seppänen T, et al. Novel spectral indexes of heart rate variability as predictors of sudden and non-sudden cardiac death after an acute myocardial infarction. Ann Med 2007; 39: 54–62
   PubMed Web of Science ®Google Scholar
• American Diabetes Association, American Psychiatric Association, American Association of Clinical Endocrinologists, North American Association for the Study of Obesity: Consensus development conference on antipsychotic drugs and obesity and diabetes. Diabetes Care 2004;27:596–601
   Google Scholar